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Abstract 
The use of nano-sized drug carriers to improve the efficiency of drug delivery has become 
well established during the past decades. New nanoparticle (NP) formulations for the 
administration of biopharmaceuticals (e.g. proteins and peptides) emerge at an increasing rate 
and the need for methods to evaluate their properties is expanding. Rational design of drug 
carriers requires understanding of their biophysical interactions with various biological 
barriers, e.g. cell membranes, mucus layers, or the blood brain barrier, since most carriers aim 
to deliver drugs across one or more of such barriers. The shape of NPs and the way they 
adhere to the cell membrane are important determinants for triggering of endocytosis. 
Another important NP parameter is their responsiveness to changes in the ambient 
environment when entering intracellular compartments e.g. the endosome or the cytosol.  
In this thesis, an in vitro screening platform for studying of NP – lipid membrane interaction 
is presented and used to characterize insulin-loaded polymeric NPs with respect to their 
interaction with differently charged supported lipid bilayers. By combining different surface 
sensitive techniques (quartz crystal microbalance with dissipation monitoring, reflectometry, 
and atomic force microscopy), structural properties of nano-sized polyelectrolyte complexes 
upon adsorption to model membranes were studied.  
From the results it is clear that electrostatic forces are important for the outcome of the NP-
lipid membrane adsorption process. Polyelectrolyte complexes, which are non covalent 
assemblies of oppositely charged polyions, adopted different shapes on different membranes. 
Upon strong electrostatic attraction between the NPs and the membrane, NPs collapsed into a 
thin layer on top of an oppositely charged model membrane. This rearrangement process is 
potentially unfavorable for uptake into epithelial cells through endocytosis. NPs based on 
polymers with disulfide linkages in the polymer backbone were responsive to reducing 
agents. This property was shown by exposing membrane-adsorbed bioreducible poly(amido 
amine) based polyelectrolyte complexes to glutathione, mimicking an intracellular reductive 
environment. Similarly, the responsiveness of the NPs towards a decrease in ambient pH, 
mimicking the low pH in the late endosome, was shown.  
These results show the application of an experimental platform based on engineered 
supported lipid membranes and surface sensitive analytical techniques to evaluate drug 
carriers with respect to their membrane interactions as well as their responsiveness. The 
information gained from screening of novel drug carries gives important guidance during the 
process of design and development. An important next step in the development of the 
presented platform will be to establish a correlation to in vitro cell culture assays. NPs for 
other purposes could also be evaluated. 
Keywords: nanomedicine, drug delivery, nanoparticle, drug carrier, supported lipid bilayer, 
cell membrane, QCM-D, in vitro screening 
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List of abbreviations  
AFM  atomic force microscopy 
DLS  dynamic light scattering  
EPR  enhanced permeability and retention  
LB  Langmuir-Blodgett 
LS  Langmuir-Schaeffer 
NP  nanoparticle 
PEC  polyelectrolyte complex 
PEG  polyethylene glycol 
POEPC  1-palmitoyl-2-oleyl-sn-glycero-3-ethylphosphocholine 
POPC  1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine 
POPS  1-palmitoyl-2-oleyl-sn-glycero-3-phospho-L-serine 
QCM-D  quartz crystal microbalance with dissipation monitoring 
RES  reticuloendothelial system 
SEM   scanning electron microscopy 
SLB   supported lipid bilayer 
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1. Introduction 
Nano-sized drug carriers are predicted to greatly improve drug administration during the 21
st
 
century.
1
 To develop new, more efficient and less toxic drugs is an extremely costly and time 
consuming process and therefore, in most cases, not considered as an option. Instead, existing 
drugs are often reformulated to improve their pharmacokinetics, i.e. the fate of the drug after 
administration. One way to achieve this is to use a carrier that allow drugs to more efficiently 
be delivered across biological barriers, and even targeted to the diseased tissue.
2
 This rapidly 
developing methodology holds a great promise because of its potential to affect (i) the 
biodegradation, (ii) the bioavailability and (iii) the potential side effects of a drug in a positive 
way. 
Rapid biodegradation of biopharmaceuticals in the bloodstream is a common problem that 
prevents a long lasting therapeutic effect, often asking for a protection of the active 
substance.
3
 The bioavailability of the drug, i.e. the fraction of the delivered dose that reaches 
the circulation system, depends on the specific properties of the drug and the chosen route of 
administration. There are several different routes to administer drugs, e.g. orally, pulmonary, 
or by injections. Some are more convenient than others and because of this they are more 
often preferred. By the use of drug carriers it could potentially be possible to alter the route of 
administration when developing new formulations, e.g. the administration of insulin by 
pulmonary delivery instead of by subcutaneous injections.
4
 It is also preferred to administer 
the smallest possible dose to obtain the desired effect since the risk of adverse side effects 
(toxicity) is decreased. By targeted drug delivery, a local high dose of the drug at its intended 
site of action can be reached while healthy tissues in other areas of the body are exposed at 
lower concentrations. This lowers the risk of adverse side effects tremendously. These drug 
carriers can, for example, also be designed as contrast agents for different imaging 
techniques.
5
 An additional advantage of small doses is that drug molecules in general and 
biopharmaceuticals in particular, are expensive to prepare. If only a small amount of the drug 
were needed the cost could be kept low.  
Different materials are used to fabricate the drug carriers and depending of the properties of 
the drug it could be incorporated in the carrier in different ways. Apart from the chemical 
properties of the carrier, physical properties like size and shape are also important 
determinants for its biological functions.
6
 Often the size of the materials used is in the 
nanometer length scale and hence they are referred to as nano carriers or nanoparticles (NPs), 
where the latter term could include both the carrier and its drug load. 
1.1. Understanding of biological barriers 
As mentioned above, NPs often need to overcome different biological barriers, e.g. mucus 
layers or cell membranes, to reach their intended target. These tasks are not trivial to achieve 
and understand, since the barriers are very effective and complex systems. However, it has 
been shown that nano-sized material can translocate across cell membranes and reach the 
cytoplasm or even the cell nucleus.
7
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To better understand the fundamental aspects of the NP - cell membrane interaction process 
the degree of complexity must be held at a minimum. One common methodology is to use a 
model system of the native cell membrane (see section 3.2).
8-10
 The basic feature of the cell 
membrane is a lipid bilayer, a structure that could be formed on hydrophilic supports such as 
SiO2.
11
 A supported lipid bilayer (SLB) is one commonly used model system for the cell 
membrane which could be studied by a variety of different surface sensitive analytical 
techniques, e.g. QCM-D and AFM.
12,13
 This type of model system has been used in this work 
and the interactions with various polymeric drug carriers have been evaluated. Apart from 
studying the NP-SLB interactions, the engineered responsiveness of NPs towards changes in 
the ambient environment, mimicking different intracellular conditions, have been evaluated. 
In this work, three different types of phospholipids have been used to form model membranes; 
these are 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleyl-sn-
glycero-3-phospho-L-serine (POPS) and 1-palmitoyl-2-oleyl-sn-glycero-3-
ethylphosphocholine (POEPC) (Figure 1). POPC and POPS occurs naturally in cell 
membranes, while POEPC is produced synthetically. POPC is a zwitterionic lipid with a net 
neutral charge. POPS and POEPC hold a net negative and positive charge respectively. 
Synthetic cationic lipids, e.g. POEPC, with various hydrophobic and hydrophilic regions have 
been developed for liposomal gene delivery. In lipoplexes, complexes between lipid structures 
and nucleic acids (e.g. DNA), electrostatic interactions play an important part.
14
 Because of 
this cationic lipids are needed to attract the polyanionic nucleic acids.  
 
Figure 1. Chemical structures of the three different lipid molecules used in this work. 
By selecting these three types of phospholipids it is possible to produce SLBs with different 
charge. Here, liposomes of POPC:POPS (3:1), POPC:POEPC (3:1) and plain POPC have 
been used to form SLBs. The complexity of the resulting SLBs is of course low compared to 
native cell membranes witch to a large extent also contain other components, see section 3.2.2 
for how to further increase the complexity. Depending on the properties of the studied NPs, 
interactions with one or more of the studied SLBs could be expected. Despite this, the 
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possibility to tune the charge of the model membrane makes it possible to evaluate the 
importance of the electrostatic attraction for membrane interactions. Furthermore, the 
integrity of the NPs upon adsorption and possible drug release could be studied as a function 
of membrane charge. 
The main focus in the presented work has been on polymeric NPs loaded with human insulin. 
Some of these NPs were not functionalized in a specific way while others contained PEG-
chains to shield the particles from surrounding substances or were designed to disintegrate 
when exposed to a reductive agent. According to the description in the next chapter these 
particles belong to the first and second generation of drug carriers depending on their 
functionalities. 
1.2. Aim 
The aim of the work presented in this thesis, and of still ongoing research, is to establish an in 
vitro screening platform of nanomaterials to study their interactions in model systems 
involving supported lipid bilayers. This experimental platform consists of a nanomaterial to 
be studied, a model membrane confined to a solid support and surface sensitive analytical 
techniques. This platform is expected to yield novel input for the design of new NPs for drug 
delivery with respect to their intrinsic properties and the way they interact with various 
biological barriers, both during the process of nanodrug development and production, and as a 
screening tool to identify potentially toxic nanomaterials.  
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2. Nanoparticle-based drug delivery  
The merging of nanotechnology and medicine is commonly referred to as Nanomedicine
15
. It 
is a rapidly expanding field of research including many different applications, such as drug 
delivery systems
16
, contrast agents for in vivo imaging
5
, sensor platforms for in vitro 
diagnostics
17
, as well as medical implants and scaffolds for tissue engineering
18
. There is a lot 
of hope and promise put into the field of Nanomedicine, but it is important to distinguish 
between the objectives that could be realized within a reasonable timescale, for the benefit of 
common health, and plain fiction. The great potential of this area arises from the fact that the 
length scale of the nanomaterials coincides with the length scale of the smallest functional 
entity in the cell, the proteins. The engineering of functional materials in the nano scale is 
predicted not only to provide a more effective interaction with living cells but also to reach 
intracellular targets. 
Many of the applications within Nanomedicine are based on the use of nano-sized particles.
19
 
For example, NPs are designed as drug carriers to protect, target, and release an active 
substance at the target site, thus minimizing adverse systemic effects.
20
 How is this achieved? 
Obviously, the NP is loaded with the drug that is going to be delivered. This construct, which 
consists of only a nano sized carrier and a drug, is referred to as the 1
st
 generation of NPs for 
drug delivery (Figure 2A).  
Apart from the drug load, the NP could also be functionalized with a targeting entity (Figure 
2B and C). This entity could for example be an antibody, part of an antibody, a peptide, or an 
aptamer. The targeting molecules then direct the drug to a specific organ or a cell type which 
express the ligand to the targeting molecule on the cell surface. For example, tumor 
biomarkers such as epidermal growth factor (EGF) receptors could be targeted for cancer 
treatments.
21
  
 
Figure 2. The 1
st
, 2
nd
 and 3
rd
 generation of drug carriers. (A) The 1
st
 generation consists of a carrier 
and its drug load. (B) In the second generation the drug carriers are functionalized, e.g. with shielding 
and/or targeting entities. (C) The third generation drug carriers contain several payloads with different 
targets. 
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When solid tumors are targeted it is possible to reach a high local concentration of NPs in the 
tumor, due to the enhanced permeability and retention (EPR) effect, without a specific 
targeting moiety. The EPR effect relates to the leakiness of the vascular tumor tissue.
22
 The 
targeting of the drug to the diseased tissue rather than having an even distribution it in the 
entire body increases the efficacy of the drug and reduces the risk of adverse side effects. At 
the site of action, the release of the active substance could either be passive or initiated by 
different methodologies depending on the nature of the NP. An active drug release could be 
achieved by heating absorbing particles through irradiation with ultrasound or light
23
 (which 
could also be the actual therapy) or by enzymatic cleavage
24
. In the latter case the carrier must 
be engineered so that it dissociates or releases the drug in any other way as a response to a 
specific enzyme present at the target site. A third approach to an active drug release is to use 
the local environment in tumors as a trigger, since tumor tissue normally has a lower pH 
compared to healthy tissue.
25
  
When the particle is functionalized with a targeting molecule and/or an active release 
mechanism they are referred to as the 2
nd
 generation of NPs for drug delivery (Figure 2B). 
The NPs could also be functionalized in additional ways. For example, it has been shown that 
pegylation of NPs can significantly prolong their residence time within the bloodstream (a 
necessary step in the direction towards so called stealth drugs).
3,26
 In this way, the foreign 
material is protected from opsonization and further elimination/degradation by the 
reticuloendothelial system (RES). When toxic substances are to be delivered, the body should 
be protected from the substance in a similar manner.  
Even more advanced approaches aim at multifunctional particles combining therapy and 
diagnostics (theranostics), such as magnetic particles which can be used both as contrast 
agents in MR imaging, and local treatment by the application of an external magnetic field. 
NPs which belong to the 3
rd
 and, so far, most advanced generation of NPs for drug delivery 
have the ability to overcome multiple biological barriers (Figure 2C). For example, particles 
could have multiple payloads where the first payload which is released at the target site is a 
NP which in turn carries the active substance further in to the diseased tissue. 
2.1. Common classes of nanoparticles for drug delivery 
Typical NP drug carrier systems include polymeric materials, inorganic materials and 
liposomes.
20
 Size, shape and surface chemistry of the NPs are important components to design 
their biological properties. The main challenge when designing a carrier for 
biopharmaceuticals is to formulate the drug load in a proper way. The drug has to be stable 
when it is attached to the carrier and active when it is released. In the following a few 
common classes on NPs are reviewed. 
2.1.1. Liposomes 
In a liposome both hydrophilic and hydrophobic environments are present which enable 
loading of drugs with totally different properties. Hydrophilic drugs could be loaded in the 
closed compartment inside the liposome and hydrophobic drugs in the interior of the lipid 
bilayer. Liposomes are the most common nanocarrier formulations used in clinic today. 
6 
 
Liposomal Doxorubicin, which is used to treat Kaposi´s sarcoma, metastatic breast cancer, 
advanced ovarian cancer, and multiple myeloma, was among the first NP formulations on the 
market. The advantage of delivering the Doxorubicin in liposomes instead of as a pure drug is 
evident when looking at the circulation half life. Free Doxorubicin has a half life of 0.2 h in 
the circulation system but this time increases to 2.5 and 55 h if the drug is administered in an 
unpegylated or a pegylated liposome respectively.
27
 Furthermore, by using liposomes as drug 
carriers an active drug release can be achieved at inflamed or cancerous tissue due to the 
enhanced activity of the secretory phosphlipase A2 (PLA2).
24
 
2.1.2. Polymeric nanoparticles 
There are many types of NPs based on organic polymers.
28
 Polymeric micelles, polymeric 
vesicles and dendrimers are some of the main groups. Another commonly used type of 
polymeric NP is polyelectrolyte complexes (PECs) which are created by mixing oppositely 
charged polyions, where one is the biopharmaceutical to be administered. PEC particles form 
spontaneously when the components are mixed and are mainly held together by strong 
electrostatic interactions. However, other interaction forces like hydrogen bonding, 
hydrophobic interactions and van der Waals forces complement the electrostatic interactions 
in PEC formation.
29
 Physical properties like hydrodynamic diameter, zeta potential, and 
polydispersity of the PECs are dependent on concentration, ionic strength, pH, and properties 
of the used polymers. Major advantages of using PECs for drug delivery purposes are that 
they have a slow rate of degradation, are prepared in water solutions, and do not alter normal 
cell function.
29
 Polycationic polymers have been widely explored for the use in PEC drug 
delivery systems since DNA, RNA, and most proteins are negatively charged at physiological 
conditions. Polymers commonly used in such drug delivery systems include biopolymers e.g. 
alginate
30
 and chitosan
30-33
 but also synthetic polymers e.g. poly(dimethylaminoethyl 
methacrylate)
34
 and poly(amido amine)s (PAAs)
35
. In this work several different PECs have 
been studied. These particles have been developed for non invasive, e.g. oral, pulmonary, or 
nasal administration of human insulin. 
2.1.3. Magnetic nanoparticles 
Magnetic NPs can be used for many different medical applications. Due to their magnetic 
properties they can be used as contrast agents for magnetic resonance imaging (MRI) or for 
magnetic separation purposes, but also to induce hyperthermia or as guidable drug carriers. 
The particles are most often made of iron oxide, magnetite (Fe3O4) or maghemite (γ-Fe2O3) 
and show magnetic properties only when exposed to a magnetic field. When used as drug 
carriers, magnetic NPs can be concentrated at the target site by a magnetic field. Either a 
permanent magnet is implanted into the tissue or an external magnetic field is applied. For the 
magnetic NPs to be attracted by a magnetic field it is important that they are big enough. Too 
small particles (10-15 nm) are hard to attract towards the blood flow. Other parameters that 
determine the movement of the NPs are the magnetic field strength and its gradient. Apart 
from being guided to the diseased tissue, the magnetic NPs can be visualized (diagnostics) 
and heated by an alternating magnetic field to induce hyperthermia or promote drug release 
(therapy). 
36,37
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2.2. Delivery of insulin using nanoparticle formulations 
Diabetes mellitus is a family of diseases in which the blood glucose levels are too high. The 
two main causes of diabetes mellitus are (1) a deficient production of insulin due to an 
autoimmune destruction of insulin producing β-cells in the pancreas and (2) an insufficient 
production of insulin to reach the desired effect, often caused by lack of response to the 
secreted hormone. These two causes are referred to as type I and type II respectively. Diabetes 
mellitus is a chronic condition which affects a tremendous number of people worldwide every 
year. Since insulin was first extracted from the pancreas in 1921 by Banting and Best, huge 
efforts have been made to administer the hormone in a convenient way for the treatment of 
the disease. The most common way to administer insulin is through subcutaneous injections 
and despite the inconvenience for the patients, no alternative routes of administrations have 
been successful so far. As early as in 1924 the first studies on inhaled insulin were published
44
 
and since then pulmonary and other non-parental routes of administration, such as 
transdermal, nasal, oral, and rectal have been investigated.
4,45
 In January 2006, Exubera
®
, an 
advanced method by Pfizer/Nektar Therapeutics based on recombinant insulin for inhalation, 
was approved by both the European and the American drug agencies (EMEA and FDA). 
Although it was the first product of its kind on the market it was withdrawn in October 2007 
due to low market acceptance.
46
 Other devices for inhaled insulin has reached phase III in 
clinical trials. One such product was AERx
® 
iDMS developed by Aradigm Corporation and 
Novo Nordisk. However, Novo Nordisk stopped all investigations on inhaled insulin shortly 
after Pfizer announced that Exubera
®
 was being withdrawn from the market. 
Insulin is often used as a model protein to develop NP formulations for proteins and peptides 
with the aim to reach a high bioavilability of the drug using non-parental routes of 
administration. Large focus lays on oral delivery due to its ease of administration and patient 
compliance. Materials that have been used to formulate insulin for oral delivery include 
polymeric hydrogels
47
, polymeric solid nanoparticles
48
 and liposomes
49
. PECs have also been 
prepared for non-invasive insulin delivery.
30,50,51
 In this work several different insulin loaded 
PECs have been studied with respect to their lipid membrane interactions. 
2.1. Endocytosis of nanoparticles 
Apart from targeting the drug carrying NP to the diseased tissue, it is often required that the 
NP and/or its drug load enters the cell to reach a therapeutic effect. The dominating process in 
which particles are taken up by a cell is called endocytosis.
38
 This process of cellular entry 
can be divided in three main parts. First, the NP is engulfed by the cell membrane forming 
membrane invaginations which in turn are released into the interior of the cell forming an 
endosome. Second, the endosomes are delivered to intracellular structures which enables 
sorting of the NPs to their final destinations. Last, the NPs are delivered either to various 
intracellular compartments, back to the extracellular environment or through the cell 
(transcytosis). Another way that NPs can pass the epithelial lining, from the apical to the 
basolateral side, is in between neighboring cells (paracellular transport, Figure 3A). One 
physical property of NPs that is an important determinant fate of the endosome is the charge. 
It has been shown that cationic biodegradable polymeric NPs passed through MDCK 
8 
 
epithelial cells (transcytosis) while anionic particles ended up in lysosomes. The route of 
entry into the cells was also dependant on the cell type.
39,40
 
Endosytosis is divided into two subsections called phagocytosis and pinocytosis (Figure 3B). 
While phagocytosis mainly occurs in specialized phagocytes, e.g. macrophages and 
neutrophils, pinosytosis occurs in all cell types. Different subtypes of pinocytosis are often 
classified according to the protein involved in the process. This classification gives rise to 
clathrin dependent and clathrin independent endocytosis. Furthermore, the clathrin 
independent pathway is divided into caveolae-mediated endocytosis, caveolae and clathrin 
independent endocytosis and macropinocytosis. 
 
Figure 3. (A) Schematic figure showing the concept of (I) transcytosis and (II) paracellular transport of 
NPs. (B) Classification of endocytosis. 
The two endocytotic pathways which are often considered for uptake of NPs are the clathrin 
dependent and the Caveolae mediated. Clathrin dependent endocytosis is present in all 
mammalian cells and responsible for nutrient uptake, e.g. iron via the transferrin receptor and 
cholesterol via the low density lipoprotein receptor. Such natural processes can be utilized for 
targeting NPs towards endocytosis by decorating them with the appropriate ligands (e.g. 
transferring) although it cannot be known that the fate of the endosome will be the same if 
targeted NPs are encapsulated.
38
  
Caveolae-mediated endocytosis occurs amongst others in endothelial cells and fibroblasts. 
Caveolae are a special type of lipid raft rich in cholesterol, sphingolipids and proteins like 
caveolin-1, cavin and dynamin which all are involved in the endocytosis process. The main 
feature of caveolae-mediated endocytosis that is of importance to nanomedicine is that it can 
bypass lysosomes and is prominent for transcytosis. Pathogens such as bacteria and viruses 
utilize caveolae-mediated endocytosis to avoid degradation.
41
 Hence, the same process is 
believed to be beneficial for delivery of biopharmaceuticals.
42
 One possible target for 
nanodrugs that has been identified in the caveolae is aminopeptidase P. 
43
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3. Cell membrane mimics 
This section briefly describes the native cell membrane with respect to composition and 
functionalities. The complexity of these systems motivates the use of membrane model 
systems to learn more about processes involving the cell membrane. Three of the most 
common model systems liposomes, supported lipid bilayers (SLBs), and Langmuir Blodgett 
films are described. 
3.1. The cell membrane 
The cell membrane is a fluid, semi permeable barrier surrounding the cell and separating the 
intracellular space from the extracellular environment. It is based on amphiphilic lipid 
molecules, i.e. molecules with one hydrophobic and one hydrophilic region. In a lipid 
membrane the lipid molecules are arranged in a two–layered shell (a bilayer) where the 
hydrophobic parts are facing each other in the interior of the membrane whereas the 
hydrophilic parts are exposed to the surroundings. The same structure is also found in many 
intracellular compartments (organelles) where it serves to separate these compartments from 
the cytoplasm, e.g. the cell nucleus, the mitochondria, the golgi apparatus, the endoplasmatic 
reticulum, the endosome, and the lysosome.  
Although the structure of the cell membrane is based on phospholipid molecules it also 
contains other molecules like proteins, glycoproteins, cholesterol and glycolipids. The amount 
of protein associated with a membrane differs between different cell types and organelles, 
although the typical protein content is about 50 % by mass.
52
 The lipid membrane is often 
described by the fluid mosaic model which was introduced in the early 1970´s where the lipid 
molecules and the associated proteins are allowed to diffuse freely within the membrane.
53
 
Although the fluid mosaic model still holds in many respects, the complexity of the cell 
membrane is today believed to be much greater. The cell membrane contains a large number 
of different lipid molecules that in some areas are heterogeneously distributed within the 
membrane, i.e. the cell membrane contains domains with different lipid compositions. These 
domains (sometimes referred to as rafts) could possibly be functional since their properties, 
e.g. with respect to lipid packing, are altered compared to the surrounding membrane.
54
  
Proteins associated to the cell membrane, integral and peripheral, allow the cell membrane to 
carry out a wide variety of different functions. These include transporting nutrients into the 
cell and waste products out, pump ions or molecules against concentration gradients to keep a 
proper pH and osmotic pressure inside the cell, form strong connections between neighboring 
cells to strengthen tissues and create anchoring points for the cytoskeleton to strengthen the 
cells. Another very important task is carried out by the membrane bound receptors which 
mediate signals from the surroundings, by binding signaling molecules (hormones or growth 
factors), to the cytosol leading to various cellular responses. As the membrane proteins play a 
key role in the cell by sensing the external environment they are important drug targets and 
much effort is put into studying this class of proteins. About 50% of the drugs on the market 
10 
 
target membrane proteins.
55
 Due to the complexity of the native cell membrane, model 
systems are commonly used to study its properties.  
3.2. Membrane model systems 
There is a strong need of better understanding the processes taking place at the cell surface. 
How does a specific protein interact with its membrane bound receptor? What mechanisms 
determine the way a foreign nano-sized particle interacts with a cell membrane? Questions 
like these are hard to assess when working with living cells due to the complexity of the 
system. By using a model system, the degree of complexity could be decreased tremendously 
and the interaction processes could be studied by a wide variety of analytical techniques, 
which are not applicable to entire cells. Following this methodology a more fundamental 
understanding of the interaction processes is gained. Common membrane model systems 
include liposomes, supported lipid bilayers, and Langmuir-Blodgett films. 
3.2.1. Liposomes 
Liposomes are spherical entities that consist of a lipid bilayer shell enclosing an aqueous 
interior.
56
 It is possible to produce liposomes in a wide range of sizes, from diameters of a few 
tenths of nanometers to several hundred micrometers. Often liposomes are referred to as lipid 
vesicles and classified according to their size and lamellarity. This classification yields small 
(SUV), large (LUV) and giant (GUV) unilamellar vesicles. Although several different 
techniques can be used to produce unilamellar vesicles, extrusion is the most common. In this 
technique, which was first introduced by Hope et. al. in 1985
57
, a lipid suspension is pressed 
back and forth through a polycarbonate membrane with a well-defined pore size. Later, in 
1991, a convenient device for extruding liposomes in volumes up to 1 mL was described and 
evaluated.
58
 By changing the pore size of the membrane the final size of the liposomes can be 
tuned. The main advantage of using liposomes instead of supported lipid bilayers is that an 
aqueous environment is present on both sides of the lipid bilayer. Due to this it is possible to 
incorporate large transmembrane proteins in their native conformation into the lipid bilayer 
shell of the liposomes. However, it is difficult to probe the interior compartment of the 
liposome which would be necessary for measuring for example charge translocations across 
the membrane. 
3.2.2. Supported lipid bilayers 
In this work, SLBs were used as a model system for the native cell membrane and are here 
described in more detail. An SLB is formed on a solid support (sensor surface), typically 
coated with SiO2, by adsorption and rupture of liposomes leading to the formation of an 
extended planar bilayer. The rupture of the adsorbed liposomes is for most lipid compositions 
initiated at a certain surface coverage due to mechanical strain between adjacent liposomes. 
The initial rupture of liposomes form patches of bilayers which in turn fuse and form a 
continuous SLB.
11,59,60
  SLBs could be formed over large areas (in the order of cm
2
) and are 
fluid in their nature. The simplest SLB consist of only one type of lipids. From this starting 
point the complexity could be increased by changing the lipid composition or the membrane 
morphology. The latter typically occur when an amphiphile is added to the membrane.
61
 Since 
the SLB is placed directly on the support, only separated by a thin layer of water molecules, 
11 
 
the incorporation of transmembrane proteins is difficult. These proteins will lose their 
mobility in the lipid membrane and their function due to the close proximity to the solid 
support. To solve this problem the SLB could be formed on a polymer cushion or a tether can 
be placed between the surface and the membrane.
62-64
 Since the SLB is confined to a solid 
support a variety of surface sensitive techniques can be used for the analyses, e.g. AFM, 
QCM-D and reflectometry.
65,66
 In Figure 4 a schematic of a SLB on a QCM-D sensor surface 
is shown. 
 
Figure 4. Schematic model of a supported lipid bilayer formed on a QCM-D sensor surface. 
 
3.2.3. Langmuir-Blodgett films 
Another commonly used model system of the cell membrane is Langmuir-Blodgett (LB) 
films
67
. The LB technique, in which the model membrane is formed, can be divided in two 
main parts. First, an organized layer of amphiphilic molecules (e.g. lipids) is formed at an air-
water interface (Langmuir monolayer) and second, a substrate is vertically passed through the 
interface transferring the Langmuir monolayer to the substrate. The substrate can be passed 
through the monolayer repeatedly, and for each pass an additional monolayer of the 
amphiphilic molecules is added. In this way it is possible to build multilayered assemblies on 
the substrate. The Langmuir monolayer, which by itself can be used as model system for the 
cell surface, is formed inside a through in which the surface area can be altered. This makes it 
possible to alter the local density and organization of the molecules by regulating the lateral 
pressure. At a surface pressure of 30 mN/m the lipid packing density is similar to a cell 
membrane.
68
 At this point, drugs or drug loaded NPs can be added to the subphase and the 
change in surface pressure can be studied.
10
 Naturally, Langmuir monolayers cannot be used 
as a model to study transport processes across a cell membrane since it only consists of one 
lipid layer and is located at an air-water interface. Despite this, this type of model system can 
be used to mimic the outer surface of a cell. Other advantages with using lipid monolayers as 
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a model system, apart from the possibility to control the surface pressure, are that the lipid 
composition, temperature and subphase content are controlled.
69
 
As mentioned, it is possible to form a bilayer on a solid support from the Langmuir monolayer 
by the LB technique. This is performed by first forming a lipid monolayer on the surface of 
the subphase and then transferring the substrate first downwards and then upwards through 
the interphase. The same result can also be obtained by a combination of the LB and the 
Langmuir-Schaeffer (LS) techniques. In the LS technique
70
, a Langmuir monolayer is formed 
and subsequently a hydrophobic substrate is placed horizontal to the subphase and kept in 
contact with the Langmuir monolayer for 30-60 s. In this way the Langmuir monolayer is 
transferred to the hydrophobic substrate. To form a lipid bilayer with a combination of the 
two techniques, the first layer if transferred by the LB technique and the second by the LS 
technique. 
  
13 
 
4. Experimental techniques 
In this section the basics of the main techniques used in this work are described. The studied 
NPs were first characterized by determining their size distribution. This was done with 
dynamic light scattering, which determines the hydrodynamic diameter of the NPs from their 
brownian motion in suspension. In the same instrument, also the zeta potential of the NPs was 
measured through electrophoretic light scattering. QCM-D was used for the main part of the 
NP-SLB interaction studies. This technique gives the change in hydrated mass when the SLB 
is exposed to the NPs and information about structural properties of adsorbed material. By 
combining this technique with reflectometry, which is sensitive to changes in refractive index 
close to the sensor surface, it was possible to determine the degree of hydration of the 
adsorbed material. To further understand the interaction processes between the NPs and the 
model membranes AFM was used to study the surface topography after NP adsorption. 
4.1. Light scattering techniques 
4.1.1. Dynamic light scattering 
Dynamic Light Scattering (DLS), also known as Photon Correlation Spectroscopy (PCS), is a 
technique that is used to determine the size of colloidal particles or macromolecules in 
solution.
71
 The technique takes advantage of the Brownian motion of particles in solution. 
Brownian motion is a stochastic process due to collisions with surrounding molecules. When 
illuminating the suspension with laser light, the light will be scattered by the particles and due 
to the Brownian motion the intensity of the scattered light will fluctuate over time. The time-
dependant fluctuation is measured and used to determine an autocorrelation function. In 
autocorrelation measurements the signal is constantly compared to itself using a small time 
shift, τ. The correlation of the signal, G, decays exponentially and the rate is determined by 
the diffusion of the particles.  
  ∫  ( )
 
 
 (   )          
     (1) 
In equation 1, B is the baseline, A the amplitude, q the scattering vector and D the 
translational diffusion coefficient. The scattering vector is calculated according to equation 2 
where n is the refractive index of the solvent, λ0 is the wavelength of the laser in vacuum and 
θ is the scattering angle.  
  
   
  
   (
 
 
)    (2) 
By measuring the speed of the Brownian motion, the translational diffusion coefficient, D, is 
obtained (eq 1). Using the Stokes-Einstein equation (eq. 3), this diffusion coefficient can be 
used to calculate the hydrodynamic diameter, DH. 
   
  
    
     (3) 
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In equation 3, k is the Boltzmann constant, T is the temperature and η is the viscosity of the 
dispersant. 
If the sample consists of several size populations it is possible to determine their individual 
sizes by using distribution algorithms.
72
 However, the result depends on several factors such 
as the relative sizes of the different populations and their relative scattering intensity as well 
as their polydispersity. The result is given as an intensity distribution where the percentage of 
the intensity of the scattered light is shown as a function of the particle size. This data could 
be recalculated to a number distribution. Since the scattering intensity is related to the particle 
diameter by a factor of 10
6
, the presence of large particles will dramatically influence the 
intensity distribution while small particles will have a much smaller effect.  
 
4.1.1. Electrophoretic light scattering 
By electrophoretic light scattering it is possible to determine the zeta potential of 
nanoparticles. Around a charged particle there exist layers of counter ions, i.e. ions of 
opposite charge. In the inner layer, the ions are tightly associated with the particle (stern 
layer) and in the outer layer the ions are more diffusely associated. Inside the diffuse layer 
there is a boundary called the slipping plane. Within the slipping plane the ions move together 
with the particle as a stable entity in an electric field. The potential at the slipping plane is 
commonly referred to as the zeta potential or mean surface charge. To determine the zeta 
potential, an electric field is applied across a suspension of the particles. When equilibrium 
between the electric and the opposing frictional forces is reached, the particles are travelling 
at a constant velocity (electrophoretic mobility, UE). This velocity is measured by laser 
doppler velocimetry. The electrophoretic mobility could then be used to calculate the zeta 
potential by using the Henry equation (eq. 4) 
   
    (  )
  
    (4) 
In equation 4, ε is the dielectric constant, z is the zeta potential, f(ka) is Henry´s function and 
η is the viscosity. When measurements are performed in aqueous media at moderate 
electrolyte concentrations, Henry´s function can be estimated to 1.5 according to the 
Smoluchowski approximation.  
4.2. QCM-D 
Quartz crystal microbalance with dissipation monitoring (QCM-D) is a technique that 
measures small mass changes on a sensor surface, and the viscoelastic properties of the 
attached material. It is a well established surface sensitive technique which has been used to 
study the formation of SLBs
59,73
 and their biomolecular interactions
74
. The sensitivity of the 
technique is very high and masses in the order of ng/cm
2
 can be detected. The technique is 
built upon a piezoelectric quartz crystal. This means that when the crystal is subjected to 
mechanical stress electric charges are generated on its surface, and when an electric field is 
applied the crystal is strained. In most QCM-D setups, AT-cut quartz crystals are used and the 
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surfaces of the disc shaped sensors are covered with thin metal electrodes. An AT-cut crystal 
is cut in an angle of 35.25° from its optical axis and oscillates in thickness shear mode when 
subjected to an oscillating electric field. Resonance occurs when the frequency of the applied 
field corresponds to the fundamental frequency of the crystal or to a corresponding 
overtone.
75
 Mass associated to the sensor surface induce a decrease in the resonance 
frequency. If the mass (macoustic) is small compared to the mass of the crystal, evenly 
distributed in a thin layer, rigidly coupled and does not slip, it is proportional to the induced 
shift in frequency (Δfz). This relationship is described by the Sauerbrey relation (eq. 5).
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    (5) 
C, the mass sensitivity constant, is -17.7 ng/(cm
2
 Hz) for an AT cut crystal with a fundamental 
frequency of 5 MHz and z (1, 3, 5, 7, 9, 11 or 13) is the number of the harmonic. In non rigid 
films, shear acoustic waves propagates differently than in the quartz crystal. Due to this, the 
crystal and the attached film cannot be considered as one unit and the Sauerbrey equation is 
no longer valid. Apart from the frequency, the dissipation factor (D) is also measured in the 
QCM-D technique. This factor derives from decay rate of the voltage over the crystal when 
the driving voltage is turned off and is described by the following relation (eq. 6).
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    (6) 
Edissipated is the energy dissipated during one period of oscillation and Estored is the energy 
stored in the oscillating system. The dissipation factor correlates to the viscoelastic properties 
of the attached material, very rigid films have low dissipation and loosely attached materials 
generates high dissipation. In QCM-D instruments all mass associated with the sensor surface 
are measured, not only the “dry” mass.  This property is evident when studying the formation 
of SLBs by liposome rupture. First, intact liposomes adsorb to the sensor surface generating 
large shifts in both frequency and dissipation. The large responses are due to the floppy 
structure on the surface and the large amount of liquid associated with the intact liposomes, 
both in their interior and between adjacent liposomes.  Second, the liposomes start to rupture 
and release the enclosed liquid to the surroundings, a process that lead to a decrease in the 
frequency and dissipation shifts. Finally, when the SLB have been formed, the frequency and 
dissipation shifts reach characteristic values of -26 Hz and < 0.5 respectively. 
 
4.3. Reflectometry 
In contrast to QCM-D, reflectometry is an optical technique. This difference in sensing 
principle makes the two techniques an excellent complement to one and other. While QCM-D 
senses the hydrated mass (macoustic) associated to the sensor surface, optical techniques only 
detects the “dry” mass (moptic).  By combining the two techniques the degree of hydration of 
the adsorbed material could be determined.
66
 Reflectometry is based on the fact that the 
optical properties, the reflectivity, of a surface changes when mass is adsorbed to it. The 
surface under study is illuminated through a prism with monochromatic, plane polarized light 
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at a certain angle of incidence. The reflected light is split in two components with different 
polarizations and the intensity ratio (S) of these two polarizations is monitored. This ratio 
changes when adsorption/desorption processes occurs at the surface and the relative changes 
is given as the output ΔR. 
   
    
  
     (7) 
S0 corresponds to the initial intensity ratio, i.e. only buffer. The optical output, ΔR, is related 
to the adsorbed mass through the following equations 
     (    )       (8) 
       
  (    )
     
    (9) 
Where d is the thickness of the adsorbed layer and n its refractive index, A is the sensitivity 
factor and dn/dc id the refractive index increment of the adsorbed material.
78
 In this work a 
prototype instrument of combined QCM-D and reflectometry has been used. This enables the 
two techniques to be used simultaneously, at the same sensor surface, and the degree of 
hydration (H) to be determined. 
  
                
         
    (10) 
4.4. AFM 
Atomic force microscopy (AFM) belongs to a family of scanning probe microscopy 
techniques which stems from the scanning tunneling microscopy (STM) technique developed 
in the early 1980´s. The invention of the AFM in 1986 made it possible to analyze all 
surfaces, not only the ones that are electrically conductive as is the case for STM. This 
advantage, together with the possibility to perform analyses in liquid environments, opened 
up the door to the field of biology. From now on it was possible to resolve features on 
biological samples much smaller than the optical diffraction limit.
79
 
The three main components in a typical instrument are the cantilever to which a sharp tip is 
attached, an optical system used to detect cantilever deflection, the piezoelectric translation 
system and feedback circuitry (Figure 5). The cantilever is usually fabricated from silicon or 
silicon nitride and has a spring constant between 0.01 and 100 N/m. The piezoelectric 
translation system typically consists of a tube made from a piezoelectric ceramic. This system 
raster scans the tip over the sample, where the movements can be controlled with high 
accuracy in three dimensions. The optical deflection system measures the bending of the 
cantilever which in turn is dependent on the tip-sample interaction (i.e. “force”).  
An AFM analysis can be performed either in contact or in tapping mode. In contact mode the 
tip will be in constant contact with the surface, and the image is created from either the 
bending of the cantilever or the movements of the cantilever base in the z-direction. These 
two ways of detection are called constant height and constant force, respectively. In the latter 
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case the data from the optical deflection system is fed into a feedback loop, which keeps the 
deflection of the cantilever (i.e. the force) constant. In tapping mode the cantilever is made to 
oscillate close to its natural resonance frequency. When the tip comes in close contact with 
the surface, the oscillation amplitude will change due to tip-sample interaction. When the tip 
is scanned across a surface, the amplitude is kept constant by the feedback loop, and the 
necessary scanner height adjustments are used to form an image. In this work, only contact 
mode AFM at constant force has been applied. 
 
 
Figure 5. Schematic illustration of an AFM setup. 
The AFM can also be used for force spectroscopy, i.e. the force is measured versus the 
distance between the tip and the sample at a fixed lateral position. With force spectroscopy, 
intermolecular forces can be measured and the force spectra can indicate the length or 
thickness of an investigated object.
80
 This is a good way to detect the presence of a SLB on a 
surface. Since the membrane is very flat and faithfully follows the contours of the underlying 
substrate, a topographic image will not easily reveal its presence. The outcome of the force 
spectra will however be different if a membrane is present compared to the bare surface. 
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5. Results 
This chapter summarizes the results presented in the appended papers. In brief, different 
insulin-loaded NPs based on polyelectrolytes, i.e. PECs, were first characterized with respect 
to size and charge and then with respect to their lipid membrane interactions using the 
techniques described in the previous chapter.  
In Paper I, differently charged SLBs were exposed to one type of PEC and the NP-membrane 
interactions were analyzed with QCM-D and a combined QCM-D/reflectometry setup. In 
addition, optical modeling of the sensitivity factor was performed. It was found that the 
positively charged PECs selectively adsorbed to negatively charged membranes and that the 
degree of negative charge determined their structural deformation upon adsorption.  
In Paper II, the responsiveness of several different PECs towards a reducing agent and a 
decrease in pH were evaluated by QCM-D and AFM. The results showed that the PECs 
collapsed upon adsorption without disrupting the underlying membrane and that PECs 
containing disulfide linkages in the polymer backbone dissociated upon addition of a reducing 
agent. A similar response was obtained when the ambient pH was decreased.  
In Paper III an attempt to make a PEC more repellant, by introducing a PEG-containing 
polymer, was evaluated. It was clear that the PEG-ylation needed to be altered since the 
desired effect was not obtained. 
5.1. Characterization of nanoparticles 
As a first step, all types of NPs that have been analyzed in this study were characterized with 
respect to their size and charge. These types of analysis were mainly performed using 
dynamic (size) and electrophoretic (charge) light scattering. The preferred sample should have 
a low polydispersity and a low variation of the mean size between different batches. In 
Paper I, the investigated NP (referred to as NP-HI) was analyzed with both DLS and SEM 
(Figure 6). The hydrodynamic diameter was determined to approximately 220 nm by DLS. In 
contrast, the size revealed by electron microscopy was much smaller (d < 100 nm). The large 
difference between these results was due to the hydration of the analyzed NPs. Prior to the 
SEM analysis, the sample are dried and the analysis is preformed under vacuum conditions 
whereas the DLS analysis is preformed in liquid. Naturally, these different sample 
preparations yield particles with different size.   
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Figure 6. Characterization of NP-HI with respect to size. (A) Intensity and (B) number distributions 
obtained by DLS. (C) SEM images of different magnifications (20 000x (inset) and 400 000x) 
visualizing the studied NPs.  (Paper 1) 
Apart from the presented example, all size characterizations of NPs were solely based on DLS 
analyses. This method was selected because of the possibility to perform the analyses under 
the same conditions as for the following QCM-D, relectometry, and AFM experiments as well 
as of the high throughput.  
5.2. Nanoparticle interaction with model membranes 
After the nanomaterials were characterized by light scattering techniques and it was 
concluded that the materials were well defined, their interaction with model lipid membranes 
were analyzed.  
Three model membranes, based on differently charged phospholipids, were used. SLBs were 
formed on a SiO2 support using positively charged (ζ-potential: 22 ± 0.8 mV) POPC:POEPC 
(3:1), neutral/slightly negatively charged (ζ-potential: -0.3 ± 1.0 mV) POPC, and negatively 
charged (ζ-potential: -26 ± 1.2 mV) POPC:POPS (3:1) liposomes. The formed SLBs were 
assumed to have similar charge as the corresponding liposomes and they typically yielded 
QCM-D responses which are characteristic for high quality SLBs; Δf = -26 Hz and ΔD < 0.5.  
In a next step, NPs were added to the formed SLBs and the outcome of the NP-SLB 
interaction was studied in real-time with QCM-D. A schematic of the experimental setup is 
presented in Figure 7. QCM-D was chosen to be the first method of analysis due to the gained 
structural information of the NP-SLB interactions and the relatively high throughput. From 
the recorded data, specific experiments were selected to be performed with other surface 
based techniques, e.g. AFM or combined QCM-D/reflectometry.  
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Figure 7. Schematic of the experimental setup where a formed SLB on a sensor surface is exposed to 
insulin-loaded PECs.  
In paper I, the studied NP (referred to as NP-HI) selectively interacted with the negatively 
charged POPC and POPC:POPS membranes. This was an expected result due to the positive 
charge of the NP-HI (ζ-potential: 26 ± 2 mV). However, the QCM-D analysis showed that the 
adsorbed NP-HI had different structural confirmations depending on the degree of negative 
charge of the membrane. 
QCM-D responses obtained when NP-HI adsorbed on a negatively charged POPC:POPS (3:1) 
membrane suggested the formation of a thin and fairly rigid structure on the membrane. A 
more loose structure was formed on a plain POPC membrane. This layer was characterized by 
high ΔD values and by large spreading between different harmonics compared to the 
POPC:POPS (3:1) membrane. To further investigate the structural differences between these 
two cases, they were analyzed in a combined QCM-D/reflectometry setup (Figure 8). The aim 
of this analysis was to compare the two different structural arrangements of the adsorbed NPs 
with respect to their degree of hydration. For  NP-HI layers adsorbed on a POPC:POPS (3:1) 
membrane, macoustic and moptic were calculated as described in section 4.2 and 4.3 respectively, 
and the degree of hydration was determined to approximately 70%. The thicker layer formed 
by adsorption of NP-HI to a plain POPC membrane generated a decrease in the optical signal 
(ΔR). This result suggests, in contrast to the QCM-D data that mass is lost from the surface. 
Hence moptic of the adsorbed NP-HI could not be determined for this case. The reason behind 
the negative optical signal was elucidated through optical modeling of the system and was 
found to be related to the thickness of the adsorbed material and not mass loss. The optical 
model and the modeled data are described in more detail in section 5.4.  
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Figure 8. QCM-D (z = 9) and corresponding reflectometry data of the adsorption of NP-HI to a 
POPC:POPS (3:1) membrane (A, B) and a plain POPC membrane (C, D). The plots show (1) a 
baseline after membrane formation, (2) adsorption of NPs and (3) buffer rinse. (Paper I) 
In both paper II and III, PEG-ylated NPs were compared with non PEG-ylated NPs. In one 
case (Paper II) the PEG-ylation reduced the positive surface charge of the NPs and to a certain 
extent prevented adsorption to a POPC:POPS (3:1) membrane. This result was in agreement 
with the general idea that PEG-ylation makes NPs more repellant and therefore prolongs the 
circulation half-life of the NPs. It was also evident that the fraction of PEG-ylated NPs that 
adsorbed to the membrane generated a more viscous arrangement on the surface compared to 
the non PEG-ylated. This was most likely due to the PEG-chains that extend from the 
polymer backbone. In contrast to the results presented in Paper II, the comparison of PEG-
ylated and non PEG-ylated NPs in Paper III revealed that the desired effect was not obtained. 
In this study, where the NPs are referred to as NP-HI (same NP as in paper I) and PEG-NP-
HI, the change in zeta-potential was small and both types of NPs adsorbed to the same extent 
to a POPC:POPS (3:1) model membrane. No adsorption occurred on a POPC:POEPC (3:1) 
membrane. The QCM-D data are shown in Figure 9. From the results it was possible to 
conclude that the PEG-ylation was not successful and the approach needs to be altered to 
obtain the desired effect. 
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Figure 9. QCM-D data of adsorption of NP-HI and PEG-NP-HI on a positively charged POPC:POEPC 
(3:1) membrane and a negatively charged POPC:POPS (3:1) membrane. Both plots show the 
following sequence of events: (1) SLB formation, (2) buffer exchange, (3) addition of NPs and (4) 
buffer rinse. (Paper III) 
5.3. Bioreduction of nanoparticles by mimicking intracellular 
degradation 
When NPs are taken up by a cell through endocytosis they are subjected to a low pH in the 
late endosome. This change in the surrounding environment can be utilized to trigger the 
release of the drug from its carrier. Similarly, the intracellular reductive environment can be 
used to disintegrate the carrier to promote drug release. In paper II, three different responsive 
PECs based on poly(amido amine)s were produced and evaluated. These NPs were responsive 
to reducing agents due to the presence of disulfide linkages
81
 in the backbone of the polymers. 
The NPs, which are referred to as NP 1-3, were also designed to disintegrate when pH was 
decreased from physiological to about 5 due to a strong decrease in the charge attraction 
between the polymer and the protein at this low pH. A fourth NP (NP 4), without disulfide 
linkages in the polymer backbone, was included in the study as a control. In this study the 
NPs were first adsorbed to a preformed POPC:POPS (3:1) membrane. Subsequently, the 
ambient conditions were altered either by adding a reducing agent (glutathione) or by 
decreasing the pH.  
1 2 3 4
1 2 3 4
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As expected, NPs containing disulfide linkages in the polymer backbone responded to the 
presence of glutathione while the NP without disulfide linkages was unaffected by the 
addition of glutathione. The previously adsorbed NPs containing disulfide linkages 
dissociated from the membrane. The QCM-D frequency shift Δf suggested that the intact lipid 
membrane remained on the surface. The percent of the adsorbed NP mass that dissociated 
from the surface in the four different cases are presented in Figure 10A.  
NP 1, was evaluated with respect to its pH-sensitivity. After adsorption to a POPC:POPS 
membrane and subsequent buffer rinse, the pH was decreased from 7.3 to 5.1 using a pH-
gradient lasting for one hour. The result shows that mass start to dissociate from the surface at 
a pH of approximately 6.5. After this point, a rapid mass release occurs until a pH-value of 
about 6. Finally, at pH 5.1, the mass loss has leveled out at a level where 20 % of the initial 
amount of mass is left on the membrane. The result is presented in Figure 10B.  
 
Figure 10. Response of the adsorbed NPs to (A) addition of a reducing agent (glutathione) and (B) a 
decrease in pH. (Paper II) 
The scenario suggested by the interpretation of the QCM-D data was further strengthened by 
AFM measurements. The adsorption of NP 1 to the model membrane and its response to 
glutathione was evaluated by imaging after the formation of the SLB, after adsorption of NPs, 
and after addition of glutathione (Figure 11). Corresponding force spectra were also recorded. 
The bare SLB was detected by a kink in the force spectrum originating from when the tip was 
pressed through the SLB during its approach towards the surface. After adsorption of NP 1, 
this characteristic kink corresponding to the SLB was still present. In addition, forces were 
Addition of reducing agent Buffer rinseA
B
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exerted on the tip several tens of nanometers away from the surface. This event in the force 
spectrum reveals the presence of the adsorbed NP material. Another main difference in the 
force spectrum after addition of NPs was the pull off force. Before addition of NPs the pull 
off was a distinct event where the tip snapped off the surface, while after addition of NPs the 
pull off occurred much more slowly. After addition of glutathione two different regions were 
revealed on the surface. Although the SLB could be detected in both, the force spectra 
suggested that in one of the regions an additional thin layer of NP material was present. 
 
Figure 11. AFM images, corresponding force spectra and schematic models (not to scale) of the bare 
lipid membrane (z-range 1.6 nm), after adsorption of NP 1 (z-range 3.0 nm) and after addition of 
glutathione (z-range 10 nm). The cross section, shown in the inset, corresponds to the white bar in the 
image. (Paper II) 
By combining the data obtained from QCM-D and AFM after NP adsorption and after 
subsequent addition of glutathione, a schematic model of the surface was made. The model, 
which is shown to the right in Figure 11, shows that the NPs collapse into a layer much 
thinner than the hydrodynamic diameter of the NPs (d = 165 ± 5 nm) when adsorbed to a 
POPC:POPS membrane. After addition of glutathione only a few nanometers thick layer 
which partially covered the surface remained. 
Both the presented cases where adsorbed NPs dissociate from the surface due to particle 
disintegration were most likely associated with release of the insulin drug load. However, to 
follow the release of insulin from its carrier other methods must be applied which in most 
cases require labeling of the insulin molecules. 
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5.4. Modeling the sensitivity factor 
In paper I, a prototype instrument which combines QCM-D and reflectometry on the same 
sensor surface was used. Due to the complementary sensing principles of the two techniques it 
was possible to determine the degree of hydration of the adsorbed material. When the 
investigated NP-HI was adsorbed to a negatively charged POPC:POPS (3:1) membrane, the 
analysis was successful. However, when the same experiment was repeated on the less 
negatively charged POPC membrane an unexpected result was obtained. The reflectometry 
signal (ΔR) decreased when the NP-HI was introduced in the system (see Figure 8D, section 
5.2).  The first, and most straightforward, interpretation of this result was that material was 
lost from the surface. This data was contradicted by the result of the simultaneous QCM-D 
analysis, which showed mass adsorption (negative Δf) and a viscous structure (high ΔD). It 
was elucidated that the decrease in ΔR upon adsorption of NPs was due to the thickness of the 
adsorbed layer. A thick adlayer gives rise to a negative sensitivity factor (A) and hence ΔR 
was negative. The dependence of the sensitivity factor on the thickness was studied by optical 
modeling using the software Wvase32 (J.A. Woollam Co. Inc., USA). First a model of the 
experimental system was created. The different layers included in the model were the 
underlying Ti (bulk, partially oxidized), 110 nm of SiO2 (thickness determined by 
ellipsometry), the SLB, the adsorbed NP-HI and the ambient medium (Figure 12A). After the 
model was created the sensitivity factor was modeled for different thicknesses of the NP-HI 
layer (Figure 12B). The obtained result showed that the sensitivity factor decreased rapidly 
with increasing thickness of the adsorbed layer and was negative between 100 and 400 nm.  
 
 
Figure 12. Modeling of the reflectometry sensitivity factor A. (A) The different layers included in the 
model and their respective thicknesses (d) and optical properties (n, k). (B) Plot showing how the 
calculated sensitivity factor varies as a function of the thickness (10-500 nm) of the NP-HI layer (grey 
in (A)). (Paper I) 
Modeling of the QCM-D data with Q-tools (Q-sense, Sweden) showed thicknesses of about 
100 nm in the experiments where ΔR decreased upon NP-HI adsorption. Hence, the observed 
decrease in the optical signal most likely is due to a too thick adlayer on the surface. This 
significant dependence of the sensitivity factor on the thickness of the adsorbed material 
limits the use of the reflectometry analysis since it is only accurate for very thin layers. 
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6. Concluding remarks and outlook 
Nanomedicine is an emerging field of research and the expanding development of nano-sized 
drug carriers motivates the establishment of an early phase in vitro screening platform. The 
methodology presented in this thesis, where surface sensitive techniques are used to 
investigate the interaction between SLBs and NPs, is suggested as an in vitro screening tool to 
evaluate and further characterize NPs, e.g. with respect to different surface chemistries and 
functionalities e.g. drug release mechanisms.  
In this work, several different NPs have been investigated and evaluated with respect to their 
intrinsic properties. For example, it has been concluded that PECs undergo structural 
rearrangements upon adsorption to an oppositely charged membrane and that the degree of 
rearrangement relates to the membrane charge. Hence, the electrostatic attraction between the 
NP and the model membrane is an important parameter in the NP-SLB interaction process. 
The chemical composition of NPs has also been addressed, e.g. the effect of introducing PEG 
in the NP formulation has been evaluated. In the two examples that were presented, one 
approach to PEG-ylate NPs clearly increased the stealth properties of the formulation while 
no significant effect was seen in the other. Furthermore, the responsiveness of NP 
formulations towards a reducing environment and a decrease in pH has been evaluated after 
adsorption to a model membrane. These analyses showed a clear NP response when adding a 
reducing agent or when decreasing the ambient pH. In both cases NPs dissociated from the 
surface due to destabilization of the formulation. Taken together, new information about the 
investigated NPs (PECs) has been gained and the use of the experimental platform has been 
shown. The experimental platform has a clear potential for further development and could 
possibly be an important substitute for early cell culture assays and eventually also contribute 
to decrease the number of in vivo experiments. 
The model membranes used in this work were supported lipid membranes consisting of one or 
two types of lipids. Although native cell membranes are much more complex, with additional 
constituents such as membrane proteins and polysaccharides, these model membranes 
represent the basic structure of the cell membrane, the lipid bilayer. One natural development 
of this experimental platform is to use more complex model membranes to further mimic the 
native cell membrane. In this way there would be a smaller gap between these studies and 
corresponding cell culture assays. The main step to overcome is to be able to form supported 
membranes using vesicles containing other molecules apart from lipids. There is, however, 
the possibility to incorporate the additional membrane constituents after formation of the 
supported lipid bilayer. One specific application of interest is to investigate the targeting 
properties of drug carriers to specific membrane receptors present in the model membranes. 
Another approach to create a more realistic model system would be to prepare liposomes from 
cultured cells and immobilize these on a surface. In this way, model systems for specific cell 
types could be used depending on the purpose of the studied NPs. The following cell types 
would be of special interest: (1) Epithelial cells present in e.g. lung, nose, or small intestine. 
When delivering drugs through the pulmonary, nasal, or oral route it must pass through 
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epithelial cells to reach the bloodstream. (2) Micro- and macrovascular endothelial cells 
present in micro capillary and larger blood vessels respectively. The NPs would encounter 
these cell types after injection in the bloodstream or after passage through an epithelial cell 
lining. (3) Brain microvascular endothelial cells which form a very tight barrier (the blood-
brain barrier) separating the brain from the rest of the body. If drugs are to be delivered to the 
brain, the blood-brain barrier needs to be overcome. Preferably the outcome of the surface 
based analysis of the interaction between the nanodrugs and the native liposomes should be 
correlated with a response obtained when the nanodrugs are exposed to the corresponding 
living cell cultures (e.g. uptake of NPs or cell count). If such a correlation is found, the 
screening of novel drug carriers could be made much more efficient. 
Furthermore, by applying additional surface sensitive techniques, it would be possible to learn 
even more about the fate of the NPs when adsorbed to the model membrane. Potentially, the 
drug release from the NPs once adsorbed to the model membrane could be evaluated. One 
preferred method to use is total internal reflection fluorescence (TIRF) microscopy. This 
technique gives a very low background signal since the fluorophores are only excited close to 
the surface because of the exponential decay of the evanescent field, compared to ordinary 
fluorescence microscopy. The main drawback is that the technique requires labeling of the 
drug molecules. 
In this work only NPs developed for drug delivery purposes have been evaluated. However, 
the described experimental platform is also promising for studies other types of 
nanomaterials. For example, the methodology could be used to relate NP characteristics to 
membrane disruption. Hence, the toxicity of NPs could be assessed.  
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